Ibogaine shows promise as PTSD treatment for veterans, but scientists still don't know how it works
By
bushwart
A touch underbaked. Edible, but you'll want a strong coffee alongside.
Summary
Ibogaine, a banned hallucinogenic compound derived from the African iboga shrub, is being studied as a potential treatment for PTSD in veterans. Trials suggest it could offer a new therapeutic approach, though scientists still don't fully understand how it works. The article highlights personal accounts like Elias Kfoury's, who says the treatment changed his life, and notes growing interest in using psychedelics for serious mental health conditions.
Key quotes
· 3 pulledElias Kfoury says the treatment he received with ibogaine changed his life
Some scientists say ibogaine's rich, subjective psychedelic experiences are central to its effect on PTSD
There is growing interest in using psychedelics to treat serious mental health conditions such as PTSD
You might also wanna read
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
